Julien Péron, Pascal Roy, T. Conroy, Françoise Desseigne, M. ychou, et al.. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma.
Oncotarget, Impact journals, 2016, 7, pp.82953-28960.
⟨10.18632/oncotarget.12761⟩.
⟨hal-02053624⟩